Filtered (2)
Filters
Category
Show (2)
Cancel
  • Multisite evaluation of the Asuragen NGS RNA Lung Cancer Kit demonstrates the assay’s superior performance
    7th February 2019NGS, Molecular Oncology, Non-Small Cell Lung Cancer

    Multisite evaluation of the Asuragen NGS RNA Lung Cancer Kit demonstrates the assay’s superior performance

    Results from a five-site study using the QuantideX NGS RNA Lung Cancer Kit* published in The Journal of Molecular Diagnostics demonstrate the assay’s high sensitivity, accuracy, and reproducibility in detecting actionable RNA [...]

  • Achieving an international scale for standardising and interpreting molecular response in Chronic Myeloid Leukaemia patients
    4th May 2018BCR-ABL1 Monitoring, Molecular Oncology

    Achieving an international scale for standardising and interpreting molecular response in Chronic Myeloid Leukaemia patients

    Advanced technology from Asuragen enables labs to reliably monitor leukaemia patients’ response to TKI therapy by reporting data on the international scale, ensuring effective CML treatment Chronic Myeloid Leukaemia (CML) affects 1.2 [...]